Manchester Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Manchester Pharmaceuticals Ownership

Who owns Manchester Pharmaceuticals?

Manchester Pharmaceuticals is owned by Travere Therapeutics. It was acquired on February 12, 2014.

Manchester Pharmaceuticals Business Overview

Where is Manchester Pharmaceuticals headquartered?

Manchester Pharmaceuticals is headquartered in Fort Collins, Colorado.

What sector is Manchester Pharmaceuticals in?

Manchester Pharmaceuticals is a life science company.

Life Science M&A Summary in 2014

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2014. The largest life science acquisition in 2014 was InterMune - which was acquired by Roche Holding AG for $8.3B.

Join Mergr to view all 236 acquisitions of life science companies in 2014, including 21 acquisitions by private equity firms, and 215 by strategics.

Manchester Pharmaceuticals, Inc.

8236 Benson Court,
Fort Collins, Colorado 80525
United States,
(970) 685-4119
www.manchesterpharma.com

Manchester Pharmaceuticals is a privately-held specialty pharmaceutical company, is focused on the identification, development, and commercialization of therapeutic modalities to address the special needs of patients with ultra-rare diseases. Manchester markets Chenodal (chenodiol tablets) and Vecamyl® (mecamylamine tablets) in the U.S. Manchester's founders and management have extensive combined experience in the rare disease market.


 Subscribe to unlock this and 201,535
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.